Dexcom is committed to providing healthcare professionals with the latest clinical evidence to demonstrate positive outcomes for Dexcom CGM.
Simply Powerful
Usability and Teachability of Continuous Glucose Monitoring Devices in Older Adults and Diabetes Educators: Task Analysis and Ease-of-Use Survey
Impact of Human Factors Testing on Medical Device Design: Validation of an Automated CGM Sensor Applicator
Accuracy
Accuracy, Utilization, and Effectiveness Comparisons of Different Continuous Glucose Monitoring Systems
Performance of a Factory-Calibrated, Real-Time Continuous Glucose Monitoring System in Pediatric Participants With Type 1 Diabetes
Performance of a Factory-Calibrated Real-time Continuous Glucose Monitoring System Utilising an Automated Sensor Applicator
A Pilot Study of the Feasibility and Accuracy of inpatient Continuous Glucose Monitoring
Comparisons of Fifth-, Sixth-. and Seventh-Generation Continuous Glucose Monitoring Systems
Accuracy and Safety of Dexcom G7 Continuous Glucose Monitoring in Adults with Diabetes
Health Outcomes
Glycemic Outcomes with Early Initiation of Continuous Glucose Monitoring System in Recently Diagnosed Patients with Type 1 Diabetes
Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections
Comparison of Different Treatment Modalities for Type I Diabetes, Including Sensor-Augmented Insulin Regimens, in 52 Weeks of Follow-Up: A COMISAIR Study
Effectiveness of Continuous Glucose Monitoring on Metrics of Glycemic Control in Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Pregnancy
Performance of the Dexcom G6 Continuous Glucose Monitoring System in Pregnant Women with Diabetes
Other
Reliability of the Dexcom G6 Continuous Glucose Monitor During Hyperbaric Oxygen Exposure
Safety of a continuous glucose monitoring device during hyperbaric exposure
Long-term cost-effectiveness of Dexcom G6 real-time continuous glucose monitoring system in people with type 1 diabetes in Australia
The Silver Lining to COVID-19: Avoiding Diabetic Ketoacidosis Admissions with Telehealth